Two-year outcome of juvenile idiopathic arthritis in current daily practice: What can we tell our patients?

Clinical and Experimental Rheumatology

Volumn 30, Issue 6, 2012, Pages 972-978

  Anink, Janneke ^a   Dolman, Koert M ^a,b   Van Den Berg, J Merlijn ^a,b   Van Veenendaal, Mira ^a   Kuijpers, Taco W ^a   Van Rossum, Marion A J ^a,b  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Arthritis; Daily clinical practice; Functional ability; Juvenile rheumatoid drug therapy; Juvenile rheumatoid radiography; Treatment outcome

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GLUCOCORTICOID; METHOTREXATE; SALAZOSULFAPYRIDINE;

ADOLESCENT; ARTHRITIS; ARTHROPATHY; ARTICLE; CHILD; CLINICAL EVALUATION; COHORT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ENTHESITIS; FEMALE; FUNCTIONAL DISEASE; HUMAN; HYPERSENSITIVITY; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; POLYARTERITIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SKIN DISEASE; TREATMENT DURATION;

ADOLESCENT; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE; ARTHROGRAPHY; CHI-SQUARE DISTRIBUTION; CHILD; DISABILITY EVALUATION; FEMALE; HUMANS; JOINTS; LOGISTIC MODELS; MALE; NETHERLANDS; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STANDARD OF CARE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872704175     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. PETTY RE, SOUTHWOOD TR, MANNERS P et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-2.
2. ADIB N, SILMAN A, THOMSON W. Outcome following onset of juvenile idiopathic inflammatory arthritis: II. predictors of outcome in juvenile arthritis. Rheumatology (Oxford) 2005; 44: 1002-7.
3. MINDEN K, NIEWERTH M, LISTING J et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46: 2392-401.
4. OEN K. Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis. Best Pract Res Clin Rheumatol 2002; 16: 347-60.
5. PACKHAM JC, HALL MA. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology (Oxford) 2002; 41: 1428-35.
6. ZAK M, PEDERSEN FK. Juvenile chronic arthritis into adulthood: a long-term followup study. Rheumatology (Oxford) 2000; 39: 198-204.
7. WALLACE CA, RUPERTO N, GIANNINI E. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004; 31: 2290-4.
8. PRINCE FH, OTTEN MH, VAN SUIJLEKOM-SMIT LW. Diagnosis and management of juvenile idiopathic arthritis. BMJ 2010; 341: c6434.
9. BEUKELMAN T, PATKAR NM, SAAG KG et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 2011; 63: 465-82.
10. BARTOLI M, TARO M, MAGNI-MANZONI S et al. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis. Ann Rheum Dis 2008; 67: 370-4.
11. FLATO B, LIEN G, SMERDEL A et al. Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years. J Rheumatol 2003; 30: 386-93.
12. MAGNANI A, PISTORIO A, MAGNI-MANZONI S et al. Achievement of a state of inactive disease at least once in the first 5 years predicts better outcome of patients with polyarticular juvenile idiopathic arthritis. J Rheumatol 2009; 36: 628-34.
13. OEN K, TUCKER L, HUBER AM et al. Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study. Arthritis Rheum 2009; 61: 1077-86.
14. SPIEGEL LR, SCHNEIDER R, LANG BA et al. Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study. Arthritis Rheum 2000; 43: 2402-9.
15. WULFFRAAT N, VAN DER NET JJ, RUPERTO N et al. The Dutch version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001; 19 (Suppl. 23): S111-5.
16. DEMPSTER H, POREPA M, YOUNG N, FELDMAN BM. The clinical meaning of functional outcome scores in children with juvenile arthritis. Arthritis Rheum 2001; 44: 1768-74.
17. ADIB N, HYRICH K, THORNTON J et al. Association between duration of symptoms and severity of disease at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study. Rheumatology (Oxford) 2008; 47: 991-5.
18. HYRICH KL, LAL SD, FOSTER HE et al. Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study. Rheumatology (Oxford) 2010; 49: 116-22.
19. NORDAL E, ZAK M, AALTO K et al. Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum 2011; 63: 2809-18.
20. OEN K, DUFFY CM, TSE SM et al. Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort. Arthritis Care Res (Hoboken) 2010; 62: 527-36.
21. WALLACE CA, HUANG B, BANDEIRA M, RAVELLI A, GIANNINI EH. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum 2005; 52: 3554-62.
22. HEILIGENHAUS A, NIEWERTH M, GANSER G, HEINZ C, MINDEN K, GERMAN UVEITIS IN CHILDHOOD STUDY G. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford) 2007; 46:1 015-9.
23. RINGOLD S, SEIDEL KD, KOEPSELL TD, WALLACE CA. Inactive disease in polyarticular juvenile idiopathic arthritis: current patterns and associations. Rheumatology (Oxford) 2009; 48: 972-7.
24. MARTINI A, LOVELL DJ. Juvenile idiopathic arthritis: state of the art and future perspectives. Ann Rheum Dis 2010; 69: 1260-3.
25. RAVELLI A, VARNIER GC, OLIVEIRA S et al. Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis. Arthritis Rheum 2011; 63: 267-75.
26. SCOTT C, MEIORIN S, FILOCAMO G et al. A reappraisal of intra-articular corticosteroid therapy in juvenile idiopathic arthritis. Clin Exp Rheumatol 2010; 28: 774-81.
27. ALBERS HM, WESSELS JA, VAN DER STRAATEN RJ et al. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis. Arthritis Rheum 2009; 61: 46-51.
28. VAN ROSSUM MA, VAN SOESBERGEN RM, BOERS M et al. Long-term outcome of juvenile idiopathic arthritis following a placebocontrolled trial: sustained benefits of early sulfasalazine treatment. Ann Rheum Dis 2007; 66: 1518-24.
29. BROOKS CD. Sulfasalazine for the management of juvenile rheumatoid arthritis. J Rheumatol 2001; 28: 845-53.
30. VAN ROSSUM MA, FISELIER TJ, FRANSSEN MJ et al. Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group. Arthritis Rheum 1998; 41: 808-16.
31. HUANG JL, CHEN LC. Sulphasalazine in the treatment of children with chronic arthritis. Clin Rheumatol 1998; 17: 359-63.
32. IMUNDO LF, JACOBS JC. Sulfasalazine therapy for juvenile rheumatoid arthritis. J Rheumatol 1996; 23: 360-6.
33. VAN DER MEER A, WULFFRAAT NM, PRAKKEN BJ, GIJSBERS B, RADEMAKER CM, SINNEMA G. Psychological side effects of MTX treatment in juvenile idiopathic arthritis: a pilot study. Clin Exp Rheumatol 2007; 25: 480-5.
34. BULATOVIC M, HEIJSTEK MW, VERKAAIK M et al. High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: development and validation of a methotrexate intolerance severity score. Arthritis Rheum 2011; 63: 2007-13.
35. DAMASIO MB, MALATTIA C, MARTINI A, TOMA P. Synovial and inflammatory diseases in childhood: role of new imaging modalities in the assessment of patients with juvenile idiopathic arthritis. Pediatr Radiol 2010; 40: 985-98.
36. MALATTIA C, DAMASIO MB, MAGNAGUAGNO F et al. Magnetic resonance imaging, ultrasonography, and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis. Arthritis Rheum 2008; 59: 1764-72.